We simultaneously measured the classical tumor biomarkers CEA, CYFRA21‐1, and SCC and found that serum CEA, CFYRA21‐1, and SCC levels were also higher in ESCC patients than in healthy controls (Figure 2). This evidence concerns the gene CEACAM5 and esophageal squamous cell carcinoma.